Alisha Charlton Sells 2,300 Shares of Pro-Dex (NASDAQ:PDEX) Stock

Pro-Dex, Inc. (NASDAQ:PDEX) CFO Alisha Charlton sold 2,300 shares of the stock in a transaction on Wednesday, September 9th. The shares were sold at an average price of $61.30, for a total transaction of $140,990.00. Following the sale, the chief financial officer directly owned 21,870 shares of the company’s stock, valued at $1,340,631. The trade was a 9.52% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Pro-Dex Trading Down 1.4%

Shares of NASDAQ:PDEX traded down $0.86 during midday trading on Thursday, hitting $59.84. 65,560 shares of the stock traded hands, compared to its average volume of 63,778. The company has a quick ratio of 2.45, a current ratio of 4.10 and a debt-to-equity ratio of 0.28. The business’s 50 day moving average is $62.39 and its two-hundred day moving average is $57.68. The stock has a market capitalization of $191.49 million, a PE ratio of 14.49 and a beta of 0.06. Pro-Dex, Inc. has a one year low of $23.47 and a one year high of $77.00.

Pro-Dex (NASDAQ:PDEX) last released its quarterly earnings data on Thursday, September 3rd. The medical instruments supplier reported $0.87 earnings per share for the quarter, topping the consensus estimate of $0.67 by $0.20. The business had revenue of $20.40 million during the quarter, compared to analysts’ expectations of $19.20 million. Pro-Dex had a return on equity of 25.13% and a net margin of 17.62%. As a group, research analysts forecast that Pro-Dex, Inc. will post 2.78 earnings per share for the current year.

Hedge Funds Weigh In On Pro-Dex

Several large investors have recently made changes to their positions in the business. Los Angeles Capital Management LLC bought a new stake in shares of Pro-Dex in the 4th quarter worth approximately $37,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in Pro-Dex during the 2nd quarter valued at approximately $50,000. Bank of America Corp DE raised its stake in Pro-Dex by 173.3% during the second quarter. Bank of America Corp DE now owns 1,692 shares of the medical instruments supplier’s stock valued at $74,000 after buying an additional 1,073 shares during the last quarter. California State Teachers Retirement System purchased a new position in Pro-Dex during the second quarter valued at $99,000. Finally, Wells Fargo & Company MN boosted its holdings in Pro-Dex by 65.4% in the fourth quarter. Wells Fargo & Company MN now owns 2,314 shares of the medical instruments supplier’s stock worth $89,000 after acquiring an additional 915 shares in the last quarter. 15.28% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

PDEX has been the topic of a number of research analyst reports. Zacks Research raised shares of Pro-Dex to a “hold” rating in a research report on Tuesday, May 19th. Wall Street Zen raised shares of Pro-Dex from a “hold” rating to a “buy” rating in a research note on Saturday, June 13th. Finally, Weiss Ratings upgraded shares of Pro-Dex from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Friday, September 4th. Two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, Pro-Dex has an average rating of “Moderate Buy” and an average target price of $70.00.

About Pro-Dex

Pro-Dex, Inc is a designer and manufacturer of precision drive systems and fluid management products serving the dental, medical, industrial and energy markets. The company specializes in high-speed, brushless micromotors and controllers, as well as pneumatic and fluid control devices, providing both standard and custom-engineered solutions for original equipment manufacturers.

Its product portfolio includes high-speed dental handpieces, turbine systems, rotary and reciprocating micro-drives, along with integrated fluid delivery systems.